ondasdechoque.org
PT-BR

Post-stroke spasticity and motor function · Randomized trial · 2026

Does adding shockwave to rehab ease ankle stiffness after a stroke?

In this trial, adding six sessions of radial shockwave to intensive stroke rehab eased calf stiffness more than rehab alone, and the ankle could be moved about 10 degrees further, vs about 3. Both results were similar at 4 and 10 pulses a second. Leg movement scores changed little in any group.

Helped more than rehabilitation alone
adults with ankle stiffness after a stroke
45
sessions over 3 weeks
6
weeks: results measured at the end of treatment
3

Good to know: Small trial (45 people). Everyone had four hours of rehab a day; results were checked at the end of the 3-week course.

Ke M, Zhou P, Li D, et al. Journal of Neuroengineering and Rehabilitation, 2026 · Read the paper ↗

How this study worked

Shockwave 4 Hz+ rehab15 peopleShockwave 10 Hz+ rehab15 peopleRehab alone15 people
People were assigned to the groups by lot. Each dot is one person.

Conceptual animation: a radial wave spreads from the applicator and weakens with distance. Not to scale. Tap the field to send a pulse.

What happened

How far the ankle could be moved

Change in passive ankle range, in degrees · start to end of the 3-week course

The ankle could be moved about 9.5 degrees further in both shockwave groups, compared with about 3 degrees with rehab alone.
Show the numbers
GroupPeopleChange (degrees)
Shockwave 4 Hz + rehab14+9.5
Shockwave 10 Hz + rehab14+9.5
Rehab alone14+2.86

The treatment

Shockwave 4 Hz + rehab

Radial, twice a week for 3 weeks

Radial wavesSpread out from the skin; strongest near the surface
Sessions
6, two a week
Pulses
2,000 per session · aimed at two spots on the calf muscle
Strength
2bar · 4 per second
Numbing
Not mentioned
Device
HMJYS-A
Everyone also got
Intensive rehabilitation, 4 hours a day, 6 days a week

Shockwave 10 Hz + rehab

Radial, twice a week for 3 weeks

Radial wavesSpread out from the skin; strongest near the surface
Sessions
6, two a week
Pulses
2,000 per session · aimed at two spots on the calf muscle
Strength
2bar · 10 per second
Numbing
Not mentioned
Device
HMJYS-A
Everyone also got
Intensive rehabilitation, 4 hours a day, 6 days a week

Compared with: The same intensive rehabilitation without shockwave

Settings are what each study used, not a prescription.

Who took part

45 adults aged 30–75 with calf stiffness after a first stroke, at one rehabilitation centre in Shenzhen, China; 42 completed all checks.

hollow squares: no final score

Shockwave 4 Hz + rehab14 of 15 measured
Shockwave 10 Hz + rehab14 of 15 measured
Rehab alone14 of 15 measured
42 of 45 people (93%) had a final score.

Side effects

Five people felt mild pain during treatment that eased soon after resting. No serious or lasting problems.

All the numbers and the full appraisal

Every reported result

FROM THE FULL PAPER

The results, in numbers.

Adults aged 30–75 years with first stroke and ankle plantar-flexor spasticity, at one Shenzhen rehabilitation department; 45 randomized and 42 completed all assessments, 14 per group.

Conventional rehabilitation control15randomized

One of 15 randomized participants was lost to follow-up; all groups received conventional rehabilitation.

4 Hz radial ESWT plus rehabilitation15randomized

One of 15 randomized participants was lost to follow-up; analyses used available data.

10 Hz radial ESWT plus rehabilitation15randomized

One of 15 randomized participants was lost to follow-up; analyses used available data.

Modified Ashworth Scale (MAS)1 reported outcome
01
After first treatment and after three weeks

Modified Ashworth Scale (MAS)

Modified Ashworth Scale (six coded levels: 0–5) ordinal scale category

After a single session, both ESWT groups improved from baseline; between the 4 and 10 Hz groups, no significant difference was reported. After three weeks, MAS change favored both ESWT groups over control (adjusted p=0.008 for 4 Hz vs control; p=0.025 for 10 Hz vs control); there was no 4 vs 10 Hz difference (>0.999). MAS is subjective, and grade I was the most common baseline grade (19 of 42).

Analysis details and source

Between-group comparisons of change; nonsignificance between frequencies does not show equivalence.

Ankle passive range of motion (PROM)1 reported outcome
02
Change from baseline to end of three-week treatment

Ankle passive range of motion (PROM)

Ankle PROM degrees as device-recorded; article does not state unit in result table

Ankle passive range of motion (PROM) · Change from baseline to end of three-week treatment · means
GroupnBaselineReported change
Conventional rehabilitation control14—2.86 (SD 2.18)
4 Hz radial ESWT plus rehabilitation14—9.5 (SD 7.65)
10 Hz radial ESWT plus rehabilitation14—9.5 (SD 5.6)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp = 0.001 overall

At three weeks, PROM differed across groups; adjusted pairwise p=0.010 (4 Hz vs control), 0.002 (10 Hz vs control), and >0.999 (4 Hz vs 10 Hz).

Kruskal–Wallis with Dunn/Bonferroni pairwise tests

Mean (SD) change was 2.86 (2.18) in control, 9.50 (7.65) at 4 Hz and 9.50 (5.60) at 10 Hz. Both ESWT groups differed from control (adjusted p=0.010 and 0.002); 4 Hz and 10 Hz did not differ (>0.999).

Analysis details and source

Source reports change summaries; active-frequency nonsignificance is not equivalence.

Lateral gastrocnemius dynamic stiffness (LGS)3 reported outcomes
03
After the first session and after three weeks; change from baseline

Lateral gastrocnemius dynamic stiffness (LGS)

MyotonPRO LGS N/m

After the first session, change was −24.33 (12.27) N/m at 4 Hz and −14.73 (8.53) at 10 Hz; between-frequency test p=0.024, Cohen’s d=−0.909. After three weeks, change was −37.22 (16.22) vs −16.24 (11.13) vs −2.67 (3.91) in 4 Hz, 10 Hz and control; overall p<0.001 and pairwise adjusted p<0.001 for 4 Hz vs control, 0.019 for 10 Hz vs control and 0.049 for 4 vs 10 Hz.

Analysis details and source

LGS is one objective muscle measure; authors interpret lower stiffness as reduced tone. Different assessment windows must not be conflated.

12
Change from baseline after three weeks (T2−T0)

Lateral gastrocnemius dynamic stiffness (LGS)

MyotonPRO LGS N/m

Lateral gastrocnemius dynamic stiffness (LGS) · Change from baseline after three weeks (T2−T0) · means
GroupnBaselineReported change
Conventional rehabilitation control14—-2.67 (SD 3.91)
4 Hz radial ESWT plus rehabilitation14—-37.22 (SD 16.22)
10 Hz radial ESWT plus rehabilitation14—-16.24 (SD 11.13)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp <0.001; adjusted control vs 4 Hz p<0.001; control vs 10 Hz p=0.019; 4 vs 10 Hz p=0.049

Three-week change across control, 4 Hz and 10 Hz ESWT

Kruskal–Wallis omnibus between-group test

Changes were −2.67 (3.91), −37.22 (16.22) and −16.24 (11.13) N/m. Overall p<0.001; adjusted p<0.001 for 4 Hz vs control, p=0.019 for 10 Hz vs control and p=0.049 for 4 vs 10 Hz. Tables 5 and 6 label the LGS row “mean (SD) or median (IQR)” without saying which applies to which group; the values are shown as printed, and the control value, whose within-group test was a Wilcoxon signed-rank test (Z = −1.540) rather than a t test, may be a median (IQR).

Analysis details and source

Table 5 reports within-group change summaries; Table 6 reports between-group tests and contrasts. Within-group change is not itself a causal treatment contrast. Median IQR widths are not represented as quartiles.

15
Change after one treatment (T1−T0)

Lateral gastrocnemius dynamic stiffness (LGS), first session

MyotonPRO LGS N/m

Lateral gastrocnemius dynamic stiffness (LGS), first session · Change after one treatment (T1−T0) · means
GroupnBaselineReported change
4 Hz radial ESWT plus rehabilitation14—-24.33 (SD 12.27)
10 Hz radial ESWT plus rehabilitation14—-14.73 (SD 8.53)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp = 0.024; Table 3 states p<0.025 threshold for between-group significance

4 Hz versus 10 Hz ESWT after one session

Independent-samples t test between ESWT groups

The reported change was −24.33 (SD 12.27) N/m at 4 Hz and −14.73 (SD 8.53) N/m at 10 Hz; the between-frequency test was p=0.024, meeting the table’s p<0.025 criterion. The trial does not establish frequency superiority on broader clinical outcomes.

Analysis details and source

Table 2 values are within-group changes; Table 3 supplies the between-group test. Preserve the published p<0.025 threshold. Values are as printed; in Table 2 the 4 Hz baseline and post-session means (314.17 and 281.95 N/m) differ by 32.22, not by the printed mean change of 24.33.

Pain during ESWT and other adverse events1 reported outcome
04
Before/after ESWT sessions during three-week course

Pain during ESWT and other adverse events

VAS and active adverse-event questioning/examination VAS units; mild pain reports

Five patients reported mild pain during treatment, resolving shortly after rest. The paper reports no severe pain or serious/persistent complication.

Analysis details and source

Active questioning and examination were described; this small trial cannot rule out uncommon harms.

Modified Ashworth Scale distribution at three weeks1 reported outcome
05
After three weeks (T2)

Modified Ashworth Scale distribution at three weeks

Modified Ashworth Scale (ordinal grades 0, I, I+, II, III) participants in each ordinal category

Observed subgroup counts; these are not randomized treatment arms.

Control, MAS grade 00 / 14
Control, grade I9 / 14
Control, grade I+3 / 14
Control, grade II2 / 14
Control, grade III0 / 14
4 Hz, grade 02 / 14
4 Hz, grade I8 / 14
4 Hz, grade I+3 / 14
4 Hz, grade II1 / 14
4 Hz, grade III0 / 14
10 Hz, grade 00 / 14
10 Hz, grade I7 / 14
10 Hz, grade I+4 / 14
10 Hz, grade II3 / 14
10 Hz, grade III0 / 14
REPORTED COMPARISON TESTp overall p=0.005; adjusted 4 Hz vs control p=0.008; 10 Hz vs control p=0.025; 4 vs 10 Hz p>0.999

MAS change, control vs 4 Hz and 10 Hz ESWT

Kruskal–Wallis between-group comparison of change with Bonferroni-adjusted pairwise tests

At T2, ordinal MAS counts were control 0/9/3/2/0, 4 Hz 2/8/3/1/0 and 10 Hz 0/7/4/3/0 across grades 0/I/I+/II/III. The group comparison of change favored both ESWT groups versus control; there was no significant 4-vs-10-Hz contrast. These are ordinal categories, not interval-scale scores.

Analysis details and source

Distributions are source counts at T2; pairwise p-values compare change from baseline (Table 6). Do not infer equivalence from p>0.999.

MAS change, ordinal1 reported outcome
06
Change from baseline after three weeks (T2−T0)

MAS change, ordinal

Modified Ashworth Scale (MAS) median ordinal points

MAS change, ordinal · Change from baseline after three weeks (T2−T0) · medians
GroupnBaselineReported change
Conventional rehabilitation control14—0
4 Hz radial ESWT plus rehabilitation14—-1
10 Hz radial ESWT plus rehabilitation14—-1

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

Median change was 0 (IQR 0) in control and −1 (IQR 1) in both ESWT groups. The overall between-group test was p=0.005; Bonferroni-adjusted comparisons: 4 Hz vs control p=0.008, 10 Hz vs control p=0.025, 4 vs 10 Hz p>0.999. IQR values are preserved in prose because the table reports IQR width, not quartile endpoints.

Analysis details and source

Table 5 reports within-group change summaries; Table 6 reports between-group tests and contrasts. Within-group change is not itself a causal treatment contrast. Median IQR widths are not represented as quartiles.

Ankle passive range of motion (PROM)1 reported outcome
07
Change from baseline after three weeks (T2−T0)

Ankle passive range of motion (PROM)

Ankle passive range of motion degrees

Ankle passive range of motion (PROM) · Change from baseline after three weeks (T2−T0) · means
GroupnBaselineReported change
Conventional rehabilitation control14—2.86 (SD 2.18)
4 Hz radial ESWT plus rehabilitation14—9.5 (SD 7.65)
10 Hz radial ESWT plus rehabilitation14—9.5 (SD 5.6)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp = 0.001; adjusted 4 Hz vs control p=0.010; 10 Hz vs control p=0.002; 4 Hz vs 10 Hz p>0.999

Three-week change across control, 4 Hz and 10 Hz ESWT

Kruskal–Wallis omnibus between-group test

Mean (SD) changes were 2.86 (2.18), 9.50 (7.65) and 9.50 (5.60) for control, 4 Hz and 10 Hz. Overall p=0.001; adjusted p=0.010 for 4 Hz vs control, 0.002 for 10 Hz vs control and >0.999 for 4 vs 10 Hz.

Analysis details and source

Table 5 reports within-group change summaries; Table 6 reports between-group tests and contrasts. Within-group change is not itself a causal treatment contrast. Median IQR widths are not represented as quartiles.

Ankle clonus score1 reported outcome
08
Change from baseline after three weeks (T2−T0)

Ankle clonus score

Ankle clonus score ordinal score units

Ankle clonus score · Change from baseline after three weeks (T2−T0) · medians
GroupnBaselineReported change
Conventional rehabilitation control14—0
4 Hz radial ESWT plus rehabilitation14—0
10 Hz radial ESWT plus rehabilitation14—-1

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp = 0.194; no adjusted pairwise results

Three-week change across control, 4 Hz and 10 Hz ESWT

Kruskal–Wallis omnibus between-group test

Median (IQR width) changes were 0 (0.25), 0 (1.00), and −1 (1.00) for control, 4 Hz and 10 Hz. The overall between-group comparison was not significant (p=0.194); no pairwise p-values were reported.

Analysis details and source

Table 5 reports within-group change summaries; Table 6 reports between-group tests and contrasts. Within-group change is not itself a causal treatment contrast. Median IQR widths are not represented as quartiles.

Medial gastrocnemius frequency (MGF)1 reported outcome
09
Change from baseline after three weeks (T2−T0)

Medial gastrocnemius frequency (MGF)

MyotonPRO MGF Hz

Medial gastrocnemius frequency (MGF) · Change from baseline after three weeks (T2−T0) · means
GroupnBaselineReported change
Conventional rehabilitation control14—-0.15 (SD 1.26)
4 Hz radial ESWT plus rehabilitation14—-1.37 (SD 1.63)
10 Hz radial ESWT plus rehabilitation14—-1.16 (SD 0.88)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp = 0.010; no adjusted pairwise results

Three-week change across control, 4 Hz and 10 Hz ESWT

Kruskal–Wallis omnibus between-group test

Changes were −0.15 (1.26), −1.37 (1.63) and −1.16 (0.88) Hz for control, 4 Hz and 10 Hz. The overall between-group p-value was 0.010, but no adjusted pairwise contrasts were supplied. The paper is inconsistent here: Table 6 does not mark p=0.010 as significant although its threshold is p<0.025, and the Results text reports no MGF difference, while the Abstract states that both ESWT groups improved MGF significantly compared with control.

Analysis details and source

Table 5 reports within-group change summaries; Table 6 reports between-group tests and contrasts. Within-group change is not itself a causal treatment contrast. Median IQR widths are not represented as quartiles.

Lateral gastrocnemius frequency (LGF)1 reported outcome
10
Change from baseline after three weeks (T2−T0)

Lateral gastrocnemius frequency (LGF)

MyotonPRO LGF Hz

Lateral gastrocnemius frequency (LGF) · Change from baseline after three weeks (T2−T0) · means
GroupnBaselineReported change
Conventional rehabilitation control14—-0.98 (SD 0.92)
4 Hz radial ESWT plus rehabilitation14—-1.91 (SD 1.77)
10 Hz radial ESWT plus rehabilitation14—-1.78 (SD 1.36)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp = 0.152; no adjusted pairwise results

Three-week change across control, 4 Hz and 10 Hz ESWT

Kruskal–Wallis omnibus between-group test

Changes were −0.98 (0.92), −1.91 (1.77) and −1.78 (1.36) Hz. The overall between-group test was not significant (p=0.152); no adjusted pairwise comparisons were reported.

Analysis details and source

Table 5 reports within-group change summaries; Table 6 reports between-group tests and contrasts. Within-group change is not itself a causal treatment contrast. Median IQR widths are not represented as quartiles.

Medial gastrocnemius dynamic stiffness (MGS)1 reported outcome
11
Change from baseline after three weeks (T2−T0)

Medial gastrocnemius dynamic stiffness (MGS)

MyotonPRO MGS N/m

Medial gastrocnemius dynamic stiffness (MGS) · Change from baseline after three weeks (T2−T0) · means
GroupnBaselineReported change
Conventional rehabilitation control14—-2.74 (SD 5.45)
4 Hz radial ESWT plus rehabilitation14—-29.05 (SD 20.39)
10 Hz radial ESWT plus rehabilitation14—-10.52 (SD 11.63)

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp <0.001; adjusted control vs 4 Hz p<0.001; control vs 10 Hz p=0.237; 4 vs 10 Hz p=0.113

Three-week change across control, 4 Hz and 10 Hz ESWT

Kruskal–Wallis omnibus between-group test

Changes were −2.74 (5.45), −29.05 (20.39) and −10.52 (11.63) N/m. Overall p<0.001; adjusted p<0.001 for 4 Hz vs control, p=0.237 for 10 Hz vs control and p=0.113 for 4 vs 10 Hz.

Analysis details and source

Table 5 reports within-group change summaries; Table 6 reports between-group tests and contrasts. Within-group change is not itself a causal treatment contrast. Median IQR widths are not represented as quartiles.

Fugl–Meyer Assessment, lower extremity (FMA-LE)1 reported outcome
13
Change from baseline after three weeks (T2−T0)

Fugl–Meyer Assessment, lower extremity (FMA-LE)

Fugl–Meyer Assessment, lower extremity median score points

Fugl–Meyer Assessment, lower extremity (FMA-LE) · Change from baseline after three weeks (T2−T0) · medians
GroupnBaselineReported change
Conventional rehabilitation control14—1
4 Hz radial ESWT plus rehabilitation14—1.5
10 Hz radial ESWT plus rehabilitation14—1

Values are group summaries identified in the caption; SD denotes standard deviation. CI is a confidence interval; IQR denotes the reported quartiles. A dash means no value was extracted for that cell.

REPORTED COMPARISON TESTp = 0.483; no adjusted pairwise results

Three-week change across control, 4 Hz and 10 Hz ESWT

Kruskal–Wallis omnibus between-group test

Median (IQR width) changes were 1.00 (1.25), 1.50 (3.00) and 1.00 (3.25) for control, 4 Hz and 10 Hz. The between-group test was not significant (p=0.483); the source reports no pairwise comparisons.

Analysis details and source

Table 5 reports within-group change summaries; Table 6 reports between-group tests and contrasts. Within-group change is not itself a causal treatment contrast. Median IQR widths are not represented as quartiles.

Modified Ashworth Scale distribution after one session1 reported outcome
14
After one treatment session (T1)

Modified Ashworth Scale distribution after one session

Modified Ashworth Scale, ordinal grade participants in each ordinal category

Observed subgroup counts; these are not randomized treatment arms.

4 Hz, grade 00 / 14
4 Hz, grade I9 / 14
4 Hz, grade I+2 / 14
4 Hz, grade II2 / 14
4 Hz, grade III1 / 14
10 Hz, grade 00 / 14
10 Hz, grade I3 / 14
10 Hz, grade I+8 / 14
10 Hz, grade II3 / 14
10 Hz, grade III0 / 14
REPORTED COMPARISON TESTp = 0.691

4 Hz versus 10 Hz ESWT

Mann–Whitney U between-group comparison of change

At this single-session time point, the article provides ordinal MAS counts for the 4 Hz and 10 Hz groups only, not the control group. Counts in grade order 0/I/I+/II/III were 0/9/2/2/1 for 4 Hz and 0/3/8/3/0 for 10 Hz. The between-frequency comparison of change was not significant (Table 3 p=0.691).

Analysis details and source

Table 2 change data are within-group; Table 3 compares changes between the two ESWT frequencies. These ordinal grades should not be treated as interval-scale scores.

How treatment was delivered
Radial ESWT parameters

HMJYS-A device; prone position; probe at the muscle–tendon junction and midpoint between the medial/lateral gastrocnemius heads; 2,000 pulses/session, 2 bar; 4 Hz or 10 Hz; six sessions over three weeks, twice weekly, with at least two days between sessions.

Conventional rehabilitation

All groups received individualized conventional rehabilitation for three weeks, six days/week and four hours/day, including physical therapy, occupational therapy, speech training and acupuncture.

Follow-up

Baseline, after the first treatment, and at the end of the three-week course; VAS pain before and after each ESWT session.

HARMS & TOLERABILITY

Five participants reported mild treatment pain that resolved after rest; no severe pain or serious/persistent complication was observed in the two ESWT groups (28 completers).

LIMITS OF THE ANALYSIS

The sample is small (14 analyzed per arm), follow-up ended with the three-week intervention, and intermediate frequencies were not tested.

The trial changed a prespecified secondary outcome during data collection and corrected the registered disease-duration criterion during manuscript preparation; these changes affect interpretation and should be reviewed alongside the protocol.

No long-term outcomes were collected; MAS grade I was the most common baseline grade (19 of 42) and only 2 participants had grade III, limiting inference for more severe spasticity.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • The sample is small (14 analyzed per arm), follow-up ended with the three-week intervention, and intermediate frequencies were not tested.
  • The trial changed a prespecified secondary outcome during data collection and corrected the registered disease-duration criterion during manuscript preparation; these changes affect interpretation and should be reviewed alongside the protocol.
  • No long-term outcomes were collected; MAS grade I was the most common baseline grade (19 of 42) and only 2 participants had grade III, limiting inference for more severe spasticity.
Research review

Source-linked critical reading

Randomized treatment-schedule comparison

Reading depthMaterial consulted
Technical source record

Complete article XML read, including methods, results, tables, figure captions, discussion, conclusion and disclosures.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Single-center prospective single-blind parallel RCT; 45 randomized 1:1:1 with concealed opaque envelopes and blinded outcome assessor. One participant per group was lost, leaving 42 (14/group). Analyses used available data.

Participants

Adults aged 30–75 with first stroke, hemiparesis and MAS grade I–III ankle plantar-flexor spasticity, 2–48 weeks after stroke. MAS grade I was the most common baseline grade (19 of 42); severe-grade subgroup inference is limited.

Intervention

HMJYS-A radial device, 2,000 pulses at 2 bar; probe at gastrocnemius muscle–tendon junction and midpoint between heads. Six sessions over three weeks, twice weekly; 4 Hz or 10 Hz. ESWT groups also received the same conventional rehabilitation.

Comparator

All groups received individualized conventional rehabilitation six days/week, four hours/day for three weeks. The control had rehabilitation without ESWT. Thus the question concerns an adjunct, not replacement.

Outcomes

Primary outcome was Modified Ashworth Scale; secondary outcomes included passive range of motion, ankle clonus, MyotonPRO muscle measures and Fugl-Meyer lower-extremity score. Immediate post-session and three-week results were reported. Between-group results were mixed by outcome.

Between-group interpretation

At three weeks, MAS and PROM changes favored both ESWT groups over control; LGS differed across groups and between 4 and 10 Hz. Many other outcomes had no between-group differences. Nonsignificance does not prove equivalent frequencies. Table 6 reports adjusted pairwise tests.

Harms

Five patients reported mild pain that resolved after rest; no serious or persistent complication was reported. Active questioning and examination were performed after sessions, but the sample is too small to characterize uncommon harms.

Limitations

Only 14 participants per arm were analyzed and no post-treatment long-term follow-up occurred. Frequency was limited to 4 and 10 Hz; MAS grade I was the most common baseline grade (19 of 42). MAS is subjective. A prespecified secondary outcome was discontinued and the eligibility duration criterion was changed during manuscript preparation.

Applicability

The findings concern selected stroke patients receiving intensive rehabilitation at one center. They do not establish durable functional benefit, stand-alone ESWT effectiveness or an optimal frequency for severe spasticity.

Research priorities

Larger multisite trials should prespecify patient-important mobility outcomes, retain transparent protocol changes, include longer follow-up and broader severity, compare frequencies and doses prospectively, and report harms systematically.

THE ORIGINAL SOURCE

Read the original article.

Efficacy of different frequencies of extracorporeal shockwave on plantar flexor spasticity of the ankle in patients with stroke: a single-center, prospective, single-blind, randomized controlled trial.

Ke M, Zhou P, Li D, Kong W, Xie C, Wang Y, Wang Z, Long J. · Journal of neuroengineering and rehabilitation · 2026

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →